PERRANPORTH SURGERY
PERRANCOOMBE, PERRANPORTH
HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 11 | 14 | 78.6% | |
| HF 4 | 2011 | 15 | 19 | 78.9% | |
| HF 4 | 2012 | 18 | 27 | 66.7% | |
| HF 4 | 2013 | 21 | 24 | 87.5% | |
| HF004 | 2014 | 10 | 13 | 76.9% | |
| HF004 | 2015 | 10 | 10 | 100.0% | |
| HF004 | 2016 | 9 | 9 | 100.0% | |
| HF004 | 2017 | 12 | 12 | 100.0% | |
| HF004 | 2018 | 15 | 15 | 100.0% | |
| HF004 | 2019 | 14 | 15 | 93.3% | |
| HF004 | 2020 | 13 | 13 | 100.0% | |
| HF006 | 2021 | 16 | 18 | 88.9% | |
| HF006 | 2022 | 68 | 69 | 98.6% | |
| HF006 | 2023 | 64 | 67 | 95.5% |
